VP, Investor Relations

About Us

Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.

Led by Tassos Giannakakos, Jay Edelberg, M.D. and Bob McDowell, Ph.D., Kardigan’s co‑founders have reunited after leading Myo Kardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.

We have a cutting‑edge discovery and translational research platform, a pipeline of late‑stage candidates, and an industry‑leading team that is driven to improve the lives of patients.

At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals.
Driven by patients and their families
, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic
—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn
, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.

Position Title:VP, Investor Relations

Department:Finance and Communications

Reports To:Brianne Jahn, CFO and Emily Faucette, chief communications officer

Location:Princeton, NJ or South San Francisco, CA – On‑site 4 days per week (Mon to Thurs)

The Vice President of Investor Relations (VP, IR) is responsible for setting strategy, leading communications and cultivating relationships with Kardigan’s investment community. With plans to go public in the future, this seasoned executive has the opportunity build and oversee the execution of a comprehensive investor relations program to effectively communicate Kardigan’s strategic direction, financial progress, growth prospects and overall value proposition to external audiences including current investors, future targets, banking partners and the research analysts.

The on‑site position has a dual reporting structure into the chief financial and communications officers and will be based in either our Princeton, NJ or South San Francisco, CA office.

• Build Kardigan’s investor relations function from the ground up, including financing strategy, IPO preparation, investor targeting, and ongoing engagement to drive clear understanding and optimal valuation of the company’s story.
• Build and cultivate strong relationships with current and potential investors, including institutional firms (biotech and generalist), family offices, and high‑net‑worth individuals.
• Leverage strong fund relationships and insight into investor behavior and market dynamics to shape Kardigan’s investor relations strategy and messaging.
• Prepare and deliver clear and concise financial reports, presentations, and other communications for investors and analysts.
• Work cross‑functionally to develop and deliver a clear, consistent, and accurate investor narrative that aligns with company‑wide communications for all external audiences.
• Communicate Kardigan’s story on a continuous, transparent and consistent basis, in compliance with corporate policies and securities regulations.
• Monitor and alert management to market trends, industry developments, competitor activity and investor sentiment; prepare proactive and reactive plans, including course corrections in messaging and relationship management as needed.
• Represent Kardigan at investor conferences, roadshows and company events to consistently engage with the investment community in a way that maximizes management’s time.
• Oversee the development of all investor‑facing materials, including investor presentations, conference call scripts, Q&A,…